Please login to the form below

Not currently logged in
Email:
Password:

Obamacare

This page shows the latest Obamacare news and features for those working in and with pharma, biotech and healthcare.

Biogen’s Spinraza overpriced, says ICER

Biogen’s Spinraza overpriced, says ICER

In his latest move, the US president looks to once again take aim at Obamacare.

Latest news

  • Trump takes aim at Obamacare with repeal move Trump takes aim at Obamacare with repeal move

    Aims to dismantle the programme. Healthcare looks set to dominate the US Presidential elections once again, after a White House call for the repeal of Obamacare sparked a swift response from ... Obamacare has extended medical insurance to more than 20

  • Democrats regain control of House in mid-terms Democrats regain control of House in mid-terms

    While attacking Obamacare was a staple of Republican campaigning ahead of Trump’s 2016 victory and afterwards, the approach seems to have backfired in a number of key seats, including Kansas’

  • Health coverage across state lines Health coverage across state lines

    Also, Obamacare customers whose incomes exceed those who qualify for subsidies will likely see sharp spikes in health insurance bills. ... Expect attorneys general in Democratic-controlled states to fight it tooth-and-nail, the same way Republican AsG

  • After failing to repeal Obamacare, Trump tries another tack After failing to repeal Obamacare, Trump tries another tack

    US President Donald Trump has launched a new assault on Obamacare, signing an executive order that will allow the sale of health insurance plans that are exempt from some of its ... Senior Democrats have accused the President of trying to undermine and

  • Loss aversion Loss aversion

    It’s even harder when you have no back-up plan. This is the undeniable lesson from the Obamacare debate that we’re witnessing. ... Before Obamacare became the law of the land, we knew that loss aversion in healthcare was a political hot potato.

More from news
Approximately 5 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • The Golden Goose The Golden Goose

    Ten years ago, around the time the Affordable Care Act, ie, Obamacare, became law, Congress passed the Biologics Price Competition and Innovation (BPCI) Act, hoping it would do for biologics what ... When efforts by the Trump administration to repeal and

  • Pharma deals continue to slide Pharma deals continue to slide

    The US pharmaceutical industry has been told that Obamacare would be repealed, prices are too high and must come down and corporate tax rates will be reduced and modified to allow ... With the dysfunctional political system in the US it is hardly

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    as Obamacare) was partially responsible for this increase in desirability. ... It will be interesting to see what impact the Trump presidency has on this trend if Obamacare is dismantled.

  • US health reforms US health reforms

    In fact, it’s safe to say most C-suite drug executives would hardly shed a tear upon news of Obamacare’s swift demise. ... I think this goes all the way back to pushing Obamacare through Congress on a partisan vote.

  • Deal Watch January 2017 Deal Watch January 2017

    bear on US drug prices and the possible revocation of Obamacare in part, if not in full.  In addition, early press coverage suggests that there may be an introduction of a

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics